Health Care & Life Sciences » Pharmaceuticals | Tus-Guhan Group Corp. Ltd.

Tus-Guhan Group Corp. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
252,145.00
199,349.60
290,806.50
309,151.10
333,237.80
179,164
Cost of Goods Sold (COGS) incl. D&A
134,778.10
108,735.80
142,395.80
160,378.30
160,627.20
106,648.60
Gross Income
117,366.80
90,613.80
148,410.70
148,772.80
172,610.50
72,515.50
SG&A Expense
185,752.10
149,800.40
110,104.00
125,847.70
159,579.60
113,985.40
EBIT
89,858.10
62,363.20
28,834.50
21,565.80
12,360.60
42,808
Unusual Expense
41,828.50
9,349.40
28.60
694.30
1,650.90
5,589.60
Non Operating Income/Expense
37,295.80
15,171.70
4,231.20
48,045.80
7,960.60
4,231.50
Interest Expense
374.50
3,632.00
4,255.00
2,882.30
740.80
1,591.10
Pretax Income
165,506.70
87,766.90
30,870.60
66,249.30
22,071.40
34,318.90
Income Tax
1,056.10
1,996.40
8,498.30
16,141.10
12,165.40
2,278
Consolidated Net Income
164,450.50
85,770.50
22,372.30
50,108.20
9,906.00
38,180.40
Net Income
164,450.50
85,770.50
22,372.30
55,175.20
19,173.80
38,180.40
Net Income After Extraordinaries
164,450.50
85,770.50
22,372.30
55,175.20
19,173.80
38,180.40
Net Income Available to Common
164,450.50
85,770.50
22,372.30
55,175.20
19,173.80
38,180.40
EPS (Basic)
0.74
0.38
0.10
0.25
0.08
0.16
Basic Shares Outstanding
223,331.30
223,331.30
223,331.30
223,331.30
232,691.20
239,471.30
EPS (Diluted)
0.74
0.38
0.10
0.25
0.08
0.16
Diluted Shares Outstanding
223,331.30
223,331.30
223,331.30
223,331.30
232,691.20
239,471.30
EBITDA
72,634.90
49,076.70
42,854.40
36,657.50
27,724.90
26,771.50
Other Operating Expense
21,472.70
3,176.60
9,472.20
1,359.20
670.40
1,338.10
Non-Operating Interest Income
3,248.10
1,819.30
689.90
214.20
4,141.80
8,335.10
Minority Interest Expense
-
-
-
5,067.00
9,267.80
-

About Tus-Guhan Group Corp.

View Profile
Address
No. 33 Yangliu Road
Hengyang Hunan 421001
China
Employees -
Website http://www.guhan.com
Updated 07/08/2019
Tus-Guhan Group Corp., Ltd. engages in the research and development, manufacture, and sale of traditional and western medicine, and biological products. It offers Chinese medicine; chemical composition such as lomefloxacin hydrochloride and sodium chloride injection, clindamycin phosphate injection, potassium chloride and glucose injection; tincture and health products. The company was founded in 1956 and is headquartered in Hengyang, China.